Universal health coverage cannot succeed with fragmented systems, weak data, and largely symbolic participation. A recent court-ordered pause to NHI implementation offers a chance to build the foundations properly, argue Dr Haseena Majid and Professor Mogie Subban.
Funding cuts over the last year or so have created a crisis for multilateral health institutions. Which institutions emerge from this crisis, and in what form, will have real consequences for the health of people in South Africa, argues Spotlight editor Marcus Low.
Despite the proven benefits of newborn hearing screening and early intervention, universal screening is not yet mandated in South Africa and is only available at a few public hospitals.
Get to know South Africa’s malaria experts as they outrun hitchhiking mosquitoes and pollution-hardy bugs while navigating a regional funding collapse and a spiralling climate crisis. Joan van Dyk reports.
Antiretroviral therapy has shifted HIV from a fatal to a chronic condition. But neuropsychiatrists say it is imperative for people living with the virus to start treatment immediately as the “duration of untreated exposure” may cause irreversible brain damage and impact long-term cognitive health. Biénne Huisman reports.
Individual rare diseases impact only a very small fraction of people, but collectively they are estimated to affect over three million in South Africa. As we mark International Rare Disease Day on 28 February, Elna Schütz assesses the state of play with rare diseases in the country.
A cutting-edge, South African-led HIV vaccine trial built on decades of research recently kicked off in Cape Town. Elri Voigt unpacks what exactly is being studied, and how the resilience, tenacity and urgency of a group of dedicated South African researchers made it possible.
In South Africa, access to weight loss medicines like Ozempic and Mounjaro remains limited to those who can shell out a few thousand Rand a month. In the second article of a Spotlight special series, Catherine Tomlinson looks at the medical need for these medicines in the country and what it would take for government to provide them in the public sector.
District managers in South Africa’s public healthcare system currently have to juggle funding from multiple government budget lines, each with different strings attached. To improve district health services, we urgently need to simplify and integrate these funding flows, argues Russell Rensburg.
In South Africa, as in many places, pharmaceutical companies are not free to change medicine prices as they wish. In his latest Inside The Box column, Dr Andy Gray unpacks how medicines prices are regulated in the country and considers how this regulatory framework might change.
From academic corridors to ministerial meetings and rural reaches, Leslie London has never shied away from speaking truth to power. Biénne Huisman speaks to the Emeritus Professor at the University of Cape Town, who, still in his bright signature shirt and trademark wry grin, continues to fight health inequity.
Bogus medical practitioners threaten the health of patients and undermines trust in doctors. The problem might be growing, but so is the fight against it. Elna Schütz reports.
